Results 111 to 120 of about 819,937 (301)
The Case for High Returns: A Study of the U.S. Pharmaceutical Industry [PDF]
, 1995 In recent years, the pharmaceutical industry has undergone intense criticism from a myriad of opponents from President Clinton to the common citizen.
Taylor \u2795, David
core +1 more source
CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao +7 more
wiley +1 more source
Persistent Bilateral [18F]THK5351 and Migrating Unilateral [18F]FDG Uptake in Anti‐LGI1 Encephalitis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Anti–leucine‐rich glioma‐inactivated 1 encephalitis (LGI1‐E) can cause persistent cognitive deficits, but the mechanisms remain unclear. A 40‐year‐old woman with LGI1‐E presented with subacute cognitive deficits and showed mild left medial temporal lobe (MTL) swelling and fluid‐attenuated inversion recovery (FLAIR) hyperintensity on initial ...
Yusuke Akitomi +8 more
wiley +1 more source
Medicina U.P.B.Objective: To identify patients’ knowledge and needs regarding pharmaceutical care services in drugstores, pharmacies-drugstores, and outpatient pharmaceutical services in Antioquia, Colombia.Methods: A descriptive cross-sectional study was conducted ...
Raquel Agudelo Guisao +4 more
doaj +1 more source
Global Competitiveness in Pharmaceuticals: A European Perspective [PDF]
The report examines the competitive position of the European pharmaceutical companies and industries, and compares them with the pharmaceutical companies and industries in other parts of the world, particularly the US.
Gambardella, Alfonso +2 more
core +1 more source
Consolidation and Innovation in the Pharmaceutical Industry: The Role of Mergers and Acquisitions in the Current Innovation Ecosystem [PDF]
, 2018 Recent changes in the pharmaceutical industry have spurred an unprecedented wave of mergers and acquisitions. Some researchers and agencies have questioned whether pharmaceutical consolidation could impede drug innovation.
Shepherd, Joanna
core +2 more sources
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos +9 more
wiley +1 more source
The simple economics of risk-sharing agreements between the NHS and the pharmaceutical industry [PDF]
The Janssen-Cilag proposal for a risk-sharing agreement regarding bortezomib received a welcome signal from NICE. The Office of Fair Trading report included risk-sharing agreements as an available tool for the National Health Service. Nonetheless, recent
Barros, Pedro Pita
core +1 more source
Karakteristik Dan Kebutuhan Pasien Diabetes Mellitus Tipe Ii Di Apotek Ubaya Terhadap Layanan Residensial (Home Care) Serta Pengaruh Layanan Tersebut Pada Penatalaksanaan Penyakit Diabetes Mellitus [PDF]
, 2011 Diabetes Mellitus (DM) merupakan penyakit kronis yang treatable dan penatalaksanaannya membutuhkan kerjasama dari berbagai pihak (dokter, farmasis, perawat dan penderita/ keluarganya).
Aditama, Lisa
core
Arthritis Care &Research, EarlyView.Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg +20 more
wiley +1 more source